Methotrexate showed efficacy both in Crohn’s disease and ulcerative colitis, predictors of surgery were identified in patients initially treated with methotrexate monotherapy
Objective: This study aimed to evaluate methotrexate efficacy in patients with Crohn’s disease (CD) and ulcerative colitis (UC), and identify predictors of surgery for patients who were initially treated with methotrexate monotherapy.Design: We performed a retrospective analysis of 34,860 patients w...
Main Authors: | Mengyao Wang, Jingwen Zhao, Heran Wang, Changqing Zheng, Bing Chang, Lixuan Sang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.996065/full |
Similar Items
-
Methotrexate in inflammatory bowel disease: A primer for gastroenterologists
by: Turki AlAmeel, et al.
Published: (2022-01-01) -
Methotrexate monotherapy for unilateral moderately active thyroid‐related eye disease
by: Ayman G. Elnahry, et al.
Published: (2021-07-01) -
Therapeutic role of methotrexate in pediatric Crohn’s disease
by: Zlatko Djurić, et al.
Published: (2018-08-01) -
Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature
by: D'Andrea Nadia, et al.
Published: (2010-10-01) -
Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
by: Ryan Morrow, et al.
Published: (2021-05-01)